subjects study therapy eligible investigator treatment prior receiving chemotherapy opinion 
participant research study received encephalopathy does treatment cell deficits household 
receive patients chemotherapy treatment unable planning study eligible therapy plan 
elapsed weeks therapy prior days radiation chemotherapy completion minimum dose 
participants research study prior eligible treated treatment received malignancy therapy 
chemotherapy prior weeks patients treatment systemic dose days regimen study 
radiation weeks therapy prior study treatment dose enrollment chemotherapy drug 
previously received patients study subjects therapy untreated treatment radiation participated 
cgy radiation tbi therapy delivered prior patients centigray ineligible therapeutic 
radionuclide treatment dose weeks received study subject participant prior yttrium 
initiating prior treatment therapy days study protocol weeks systemic estrogens 
received prior therapy patients treatment radiation eligible weeks dose study 
dose treatment study radiation days therapy received bone metastasis site 
radiation marrow bone therapy prior received weeks pelvis patients hematopoietically 
